AisenbergA. C.: Quantitative estimation of the reactivity of normal and Hodgkin's disease lymphocytes with thymidine-2-C-14.Nature, 205: 1233–1234, 1965.
2.
BergJ. W.: Inflammation and prognosis in breast cancer. A search for host resistance.Cancer, 12: 714–720, 1959.
3.
BirbeckM. S., HallJ. G.: Transformation, in vivo, of basophilic lymph cells into plasma cells.Nature (London), 214: 183–185, 1967.
4.
BlackM. M., KerpaS., SpeerF. D.: Lymph-node structure in patients with cancer of breast.Amer. J. Path., 29: 505–521, 1963.
5.
BlackM. M., OplerS. R., SpeerF. D.: Microscopic structure of gastric carcinomas and their regional lymph nodes in relation to survival.Surg. Gynec. Obstet., 98: 725–734, 1954.
6.
BlackM. M., OplerS. R., SpeerF. D.: Survival in breast cancer cases in relation to structure of primary tumor and regional lymph nodes.Surg. Gynec. Obst., 100: 543–551, 1965.
7.
BlackM. M., OplerS. R., SpeerF. D.: Structural representations of tumor-host relationships in gastric carcinoma.Surg. Gynec. Obstet., 102: 599–603, 1956.
8.
BlaeseR. M., OppenheimJ. J., SeegerR., WaldmannT. A.: In vitro lymphocyte transformation. The restoration of purified lymphocyte responses by allogeneic macrophages from normal and anergic patients.Clin. Res., 18: 422, 1970.
9.
BrownR. S., HaynesH. A., FoleyH. T., GodwinH. A., BerardC. W., CarboneP. P.: Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients.Ann. Intern. Med., 67: 291–302, 1967.
10.
CrowtherD., FairleyG. H., SewellR. L.: The periodic acid - Schiff reaction of lymphocytes in human malignant disease.Brit. J. Haemat., 16: 389–396, 1969.
11.
CrowtherD., FairleyG. H., SewellR. L.: Significance of the changes in the circulating lymphoid cells in Hodgkin's disease.Brit. Med. J., 2: 473–477, 1969.
12.
CutlerS. J., BlackM. M., FriedellG. H., VidoneR. A., GoldenbergI. S.: Prognostic factors in cancer of the female breast. II. Reproducibility of histopathology classification.Cancer, 19: 75–82, 1966.
13.
CutlerS. J., BlackM. M., GoldenbergI. S.: Prognostic factors in cancer of the female breast.Cancer, 16: 1589–1597, 1963.
14.
GoodR. A., KellyW. D., RotsteinJ., VarcoR. L.: Immunological deficiency diseases. A gammaglobulinemia, hypogammaglobulinemia, Hodgkin's disease and sarcoidosis.Progr. Allerg., 6: 187–319, 1962.
15.
GowansJ. L.: The role of lymphocytes in the destruction of homografts.Brit. Med. Bull., 21: 106–110, 1965.
GrifoniV., RugarliC., TossiB., BesanaC., ScorzaR.: Effetti di estratti linfonodali autologhi su culture di linfociti di soggetti con malattia di Hodgkin.Haematologica, 53: 958–968, 1968.
18.
HallJ. G.: Studies of the cells in the afferent and efferent lymph of lymph nodes draining the site of skin homografts.J. Exp. Med., 125: 737–754, 1967.
19.
HershE. M., ButlerW. T., RossenR. D., MorgenR. O.: Activated lymphocytes (AL): a rapid test to detect allograft rejection.Clin. Res., 18: 425, 1970.
20.
HershE. M., IrvinW. S.: Blastogenic responsese of lymphocytes from patients with untreated and treated lymphomas.Lymphology, 2: 150–160, 1969.
21.
HershE. M., IrvinW. S., StanfordU.: Culture of lymphocytes from patients with untreated and treated Hodgkin's disease.Proc. Amer. Ass. Cancer Res., 7: 30, 1966.
22.
HershE. M., OppenheimI. J.: Impaired in vitro lymphocyte transformation in Hodgkin's disease.New Eng. J. Med., 273: 1006–1012, 1965.
23.
KaplanH. S., SmithersD. W.: Auto-immunity in man and homologous disease in mice in relation to the malignant lymphomas.Lancet, 2: 1–4, 1959.
24.
KassulkaJ. T., HallgrenH. M., YunisE. J.: Studies of red cells isoantigen on peripheral leukocytes from normal and leukemic individuals.Amer. J. Path., 56: 333–349, 1969.
25.
LukesR. J.: Relationship of histologic features to clinical stages in Hodgkin's disease.Amer. J. Roentgen., 90: 944–955, 1963.
26.
McCluskeyR. T., BenacerrafB., McCluskeyJ. M.: Studies on the specificity of the cellular infiltrate in delayed hypersensitivity reactions.J. Immunol., 90: 466–470, 1963.
27.
MarshallA. H. E., WoodC.: The involvement of the thymus in Hodgkin's disease.J. Path Bact., 73: 163–166, 1957.
28.
MüftüogluA. U., BalkuvS.: Passive transfer of tuberculin sensitivity to patients with Hodgkin's disease.New Eng. J. Med., 277: 126–129, 1967.
29.
OrderS. E., PorterM., HellmanS.: Hodgkin's disease: evidence for a tumor-associated antigen.New Eng. J. Med., 285: 471–474, 1971.
30.
RosenthalS. R.: Significance of tissue lymphocytes in the prognosis of lymphogranulomatosis. A.M.A.Arch Path., 21: 628–646, 1936.
31.
SalmonC.: A tentative approach to variations in ABH and associated erythrocyte antigens.Series Haemat., 2: 3–33, 1969.
32.
SheagrenJ. N., BlockJ. B., WolffS. M.: Reticuloendothelial system phagocitic function in patients with Hodgkin's disease.J. Clin. Invest., 46: 855–862, 1967.
33.
SteinerP. E., MaimonS. N., PalmerW. L., KirsnerI. B.: Gastric cancer: morphologic factors in five-year survival after gastrectomy.Amer. J. Path., 24: 947–969, 1948.
34.
TurkW.: Klinische Untersuchungen über des Verhalten des Blutes dei akuten Infections Krankheiten.Wien, 1898.
35.
WartmanW. B.: Sinus cell hyperplasia of lymph nodes regional to adenocarcinoma of the breast and colon.Brit. J. Cancer, 13: 389–397, 1959.
